JUN 10, 2019 7:24 AM PDT

CRISPR 2.0: Using Transposons to Improve and Expand CRISPR Application

WRITTEN BY: Amanda Mikyska

Source: Science showing cas12k binging and gene insertion. 

CRISPR-cas9, commonly referred to simply as CRISPR, is a bacterial immune system that was first used as a gene-editing tool in 2012.  Since the first application to gene-editing, CRISPR has made gene-editing faster, easy to design, and easy to execute.  Resistance to CRISPR in human gene therapy is due to the risk of "off-target" effects.  Though the risk is small, and debated, off-target effects can be devastating and irreversible.  Additionally, CRISPR is very useful in deleting or inactivating genes, but scientists have found it very difficult to use it to insert or repair genes.  While studies that demonstrate CRISPR's application continues, some scientists like Feng Zhang at the Broad Institute, have focused on making CRISPR more precise.  

A team of scientists from the Broad Institute and the National Institutes of Health have engineered a CRISPR system which makes use of transposon activity to increase the specificity of gene-insertion and decrease the risk of off-target effects.  The new mechanism is a sandwich with a shCAST loci in the middle, a transposase gene at one end, and a  cas12k protein at the other.  The shCAST locus is a type of CRISPR system which was isolated from a cyanobacterium.  The job of shCAST is to integrate DNA at a specific site determined by the transposase.  The transposase gene is called Tn-7, and like all transposons (or, "jumping genes") it can move around the genome.  Tn-7 copies and pastes the gene it is attached to it in the engineered sandwich.  Tn-7 precisely identifies the insertion site 60-66bp downstream of the protospacer sequence in shCAST.  Lastly, cas12k is a protein sequence with the function of finding the protospacer sequence for Tn-7.  All together, cas12k finds the protosequence, Tn-7 moves 60-66bp downstream of that sequence and then makes copies of the gene intended for insertion.  Finally, shCAST inserts copies of the gene that Tn-7 synthesized.  

Source: Harvard showing a basic schematic of transposons. 

This new gene-editing technology has a successful insertion rate of 80% but has only been tested in bacterial organisms.  Extensive experimentation in eukaryotic cells is needed before the technology can be considered for medical application.  Still, finding possible solutions to the risks of CRISPR, only seven years after the groundbreaking technology was first used as a gene-editing tool, is exciting.

 

Sources: Discover Magazine, Science, GenomeWeb, NewScientist, Harvard

About the Author
  • Amanda graduated for the University of Massachusetts Boston with a degree in Biology. After working in research on creating biochemicals from genetically engineered yeast, she started freelance science writing while traveling the world. She writes about the latest research in Neuroscience, Genetics & Genomics, and Immunology. Interested in working on solutions for food/water security, sustainable fuel, and sustainable farming. Amanda is an avid skier, podcast listener, and has run two triathlons.
You May Also Like
NOV 28, 2019
Genetics & Genomics
NOV 28, 2019
Promising New Treatment for Mitochondrial Disease Found in Fruit Flies
Researchers at the University of Cambridge have discovered a protein in fruit flies that can reverse the effects of harmful mutations in mitochondrial gene...
DEC 12, 2019
Cell & Molecular Biology
DEC 12, 2019
Newly Identified Small Proteins Could Have a Big Impact
While the human genome has been sequenced, there are plenty of parts of it that we don't know much about....
DEC 31, 2019
Genetics & Genomics
DEC 31, 2019
Using Machine Learning to Analyze Gene Regulation
Computational tools are becoming increasingly important in biological research. Now scientists have found a way to use machine learning in a way that will make sense to biologists....
JAN 03, 2020
Cardiology
JAN 03, 2020
Healthy Sleep May Offset Genetic Heart Disease Risk
People with a high genetic risk of heart disease or stroke may be able to offset that risk with healthy sleep patterns, according to new research. The rese...
JAN 24, 2020
Genetics & Genomics
JAN 24, 2020
As Sperm Mature, They Scan Their DNA and Repair Errors They FInd
Researchers have learned that when sperm cells mature, they activate many of their genes, which enables a repair process to take place....
FEB 09, 2020
Genetics & Genomics
FEB 09, 2020
Mosquitoes are Driven to Search for Heat in the Hunt for Meals
Mosquitoes can be dangerous disease vectors, and they infect and kill hundreds of thousands of people with illnesses like dengue, malaria, and West Nile Virus....
Loading Comments...